VIR
Vir Biotechnology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.26
-0.22 ▼ -2.32%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$9.22
-0.04 ▼ -0.44%
| Index | RUT | P/E | - | EPS (ttm) | -3.16 | Insider Own | 31.95% | Shs Outstand | 0.14B | Perf Week | -3.04% |
| Market Cap | 1.48B | Forward P/E | - | EPS next Y | -12.87% | Insider Trans | -5.91% | Shs Float | 0.09B | Perf Month | 24.8% |
| Enterprise Value | 1.11B | PEG | - | EPS next Q | -0.1 | Inst Own | 56.62% | Short Float | 14.4% | Perf Quarter | 41.37% |
| Income | -0.44B | P/S | 21.58 | EPS this Y | 35.35% | Inst Trans | 2.52% | Short Ratio | 3.9 | Perf Half Y | 77.06% |
| Sales | 0.07B | P/B | 1.69 | EPS next 5Y | 19.87% | ROA | -35.78% | Short Interest | 13.68M | Perf YTD | 53.57% |
| Book/sh | 5.49 | P/C | 3.16 | EPS past 3/5Y | - -4.76% | ROE | -45.73% | 52W High | -15.36% ($10.94) | Perf Year | 32.29% |
| Cash/sh | 2.93 | P/FCF | - | Sales past 3/5Y | -65.12% -2.14% | ROIC | -51.27% | 52W Low | 122.86% ($4.16) | Perf 3Y | -58.94% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.32% | Gross Margin | 82.92% | Volatility(W/M) | 5.85% 7.63% | Perf 5Y | -82.47% |
| Dividend TTM | - | EV/Sales | 16.17 | Sales Y/Y TTM | -7.61% | Oper. Margin | -682.68% | ATR (14) | 0.7 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.54 | EPS Q/Q | 59.67% | Profit Margin | -638.87% | RSI (14) | 56.5 | Recom | 1.1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.54 | Sales Q/Q | 417.78% | SMA20 | 3.92% ($8.91) | Beta | 1.67 | Target Price | $20.78 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2000000 | SMA50 | 20.59% ($7.68) | Rel Volume | 0.74 | Prev Close | $9.48 |
| Employees | 367 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | 36.88% 221.87% | SMA200 | 53.61% ($6.03) | Avg Volume(3M) | 3.51M | Price | $9.26 |
| IPO | 2019/10/11 | Option/Short | Yes/Yes | Trades | 12621 | Volume | 2,612,536 | Change | -2.32% |
뉴스 로딩 중...